MA53178A - CYCLIC DINUCLEOTIDES AS STING AGONISTS - Google Patents

CYCLIC DINUCLEOTIDES AS STING AGONISTS

Info

Publication number
MA53178A
MA53178A MA053178A MA53178A MA53178A MA 53178 A MA53178 A MA 53178A MA 053178 A MA053178 A MA 053178A MA 53178 A MA53178 A MA 53178A MA 53178 A MA53178 A MA 53178A
Authority
MA
Morocco
Prior art keywords
sting agonists
cyclic dinucleotides
dinucleotides
cyclic
sting
Prior art date
Application number
MA053178A
Other languages
French (fr)
Inventor
Leonid Beigelman
Gilles Bignan
Peter J Connolly
James P Edwards
Stuart Emanuel
Mark Richter
Wim Bert Griet Schepens
Santhosh Kumar Thatikonda
Johannes Wilhelmus J F Thuring
Marcel Viellevoye
Guangyi Wang
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of MA53178A publication Critical patent/MA53178A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
MA053178A 2018-07-17 2019-07-16 CYCLIC DINUCLEOTIDES AS STING AGONISTS MA53178A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862699001P 2018-07-17 2018-07-17

Publications (1)

Publication Number Publication Date
MA53178A true MA53178A (en) 2021-05-26

Family

ID=67999987

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053178A MA53178A (en) 2018-07-17 2019-07-16 CYCLIC DINUCLEOTIDES AS STING AGONISTS

Country Status (20)

Country Link
US (2) US11597746B2 (en)
EP (1) EP3823976A1 (en)
JP (1) JP2021531277A (en)
KR (1) KR20210033026A (en)
CN (1) CN112424212A (en)
AR (1) AR122240A1 (en)
AU (1) AU2019304230B2 (en)
BR (1) BR112021000693A2 (en)
CA (1) CA3106602A1 (en)
EA (1) EA202190298A1 (en)
EC (1) ECSP21003171A (en)
IL (1) IL280105A (en)
MA (1) MA53178A (en)
MX (1) MX2021000625A (en)
PE (1) PE20211636A1 (en)
PH (1) PH12020552172A1 (en)
SG (1) SG11202012624RA (en)
TW (1) TW202030199A (en)
UY (1) UY38304A (en)
WO (1) WO2020016782A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019118839A1 (en) * 2017-12-15 2019-06-20 Janssen Biotech, Inc. Cyclic dinucleotides as sting agonists
TW202030199A (en) * 2018-07-17 2020-08-16 美商健生生物科技公司 Cyclic dinucleotides as sting agonists
KR20220167275A (en) 2020-04-10 2022-12-20 오노 야꾸힝 고교 가부시키가이샤 cancer treatment methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020113165A (en) * 2015-12-03 2020-06-09 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед CYCLIC PURINE DINUCLEOTIDES AS STING MODULATORS
WO2017123657A1 (en) * 2016-01-11 2017-07-20 Gary Glick Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
PE20181330A1 (en) * 2016-01-11 2018-08-20 Innate Tumor Immunity Inc CYCLIC DINUCLEOTIDES TO TREAT CONDITIONS ASSOCIATED WITH ACTIVITY OF THE INTERFERON GENES STIMULATOR (STING) SUCH AS CANCER
WO2017161349A1 (en) * 2016-03-18 2017-09-21 Immune Sensor, Llc Cyclic di-nucleotide compounds and methods of use
AU2017293781B2 (en) * 2016-07-06 2022-12-22 F-star Therapeutics, Inc. Compounds, compositions, and methods for the treatment of disease
WO2018045204A1 (en) * 2016-08-31 2018-03-08 Ifm Therapeutics, Inc Cyclic dinucleotide analogs for treating conditions associated with sting (stimulator of interferon genes) activity
JOP20170188A1 (en) * 2016-11-25 2019-01-30 Janssen Biotech Inc Cyclic dinucleotides as sting agonists
TW202030199A (en) * 2018-07-17 2020-08-16 美商健生生物科技公司 Cyclic dinucleotides as sting agonists

Also Published As

Publication number Publication date
JP2021531277A (en) 2021-11-18
BR112021000693A2 (en) 2021-04-13
AU2019304230B2 (en) 2023-08-31
SG11202012624RA (en) 2021-02-25
KR20210033026A (en) 2021-03-25
US20230287034A1 (en) 2023-09-14
WO2020016782A1 (en) 2020-01-23
AR122240A1 (en) 2022-08-31
CA3106602A1 (en) 2020-01-23
PE20211636A1 (en) 2021-08-24
AU2019304230A1 (en) 2021-01-14
IL280105A (en) 2021-03-01
MX2021000625A (en) 2021-03-25
TW202030199A (en) 2020-08-16
PH12020552172A1 (en) 2021-06-07
ECSP21003171A (en) 2021-02-26
US20210277046A1 (en) 2021-09-09
US11597746B2 (en) 2023-03-07
CN112424212A (en) 2021-02-26
EP3823976A1 (en) 2021-05-26
EA202190298A1 (en) 2021-04-16
UY38304A (en) 2020-01-31

Similar Documents

Publication Publication Date Title
MA52189A (en) BENZOTHIOPHENS AND ASSOCIATED COMPOUNDS USED AS STING AGONISTS
MA46452A (en) BENZO [B] THIOPHENE COMPOUNDS AS STING AGONISTS
MA42608A (en) CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS (INTERFERON GENE STIMULATOR)
DK3512861T3 (en) CYCLIC DINUCLEOTIDES AS STING (STIMULATOR OF INTERFERONGENES) AGONISTS
MA48994A (en) ISOQUINOLEINS USED AS HPK1 INHIBITORS
MA47123A (en) BENZOOXAZOLE DERIVATIVES AS MMUNOMODULATORS
MA52486A (en) PYRIDAZINONES USED AS PARP7 INHIBITORS
MA49566A (en) CARBOXAMIDES USED AS SODIUM CHANNEL INHIBITORS
MA54546A (en) HETEROARYL AMIDES USEFUL AS KIF18A INHIBITORS
MA54547A (en) HETEROARYL AMIDES USEFUL AS KIF18A INHIBITORS
MA54076A (en) 2-AMINO-N-HETEROARYL-NICOTINAMIDE USED AS NAV1.8 INHIBITORS
EP3621624A4 (en) Cyclic di-nucleotide compounds as sting agonists
MA49563A (en) BISPECIFIC ANTIBODIES AS CONTROL POINT INHIBITORS
MA51232A (en) INDANE-AMINES USEFUL AS PD-L1 ANTAGONISTS
MA41551A (en) BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
MA42032A (en) 3-ARYL-4-AMIDO-BICYCLO [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
MA47460A (en) AMINOTRIAZOLOPYRIDINES USED AS KINASE INHIBITORS
MA48803A (en) 6-5 MERGED CYCLES USED AS C5A INHIBITORS
MA54567A (en) PYRIDINE AND PYRIDIMINE COMPOUNDS AS PI3K-GAMMA INHIBITORS
MA46180A (en) ANALOGUES OF AMYLINE
MA53178A (en) CYCLIC DINUCLEOTIDES AS STING AGONISTS
MA47736A (en) USEFUL PYRIMIDOPYRIMIDINONES AS KINASE WEE-1 INHIBITORS
MA53110A (en) POLYCYCLIC COMPOUNDS AS BRUTON TYROSINE KINASE INHIBITORS
DK3752516T3 (en) CYCLIC DINUCLEOTIDES AS ANTICANCY AGENTS
MA50013A (en) BENZOAZPINE ANALOGUES USED AS BRUTON TYROSINE KINASE INHIBITORS